The Multiple Myeloma Channel is supported with funding from AbbVie (Platinum), Sanofi (Gold), Legend Biotech (Bronze), and through an educational grant from Alexion Pharma GmbH.
VJHemOnc is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
COMy 2022 | Highlights from COMy 2022: day 1
In this video, we hear Irene Ghobrial, MD, Dana-Farber Cancer Institute, Boston, MA, Elena Zamagni, MD, PhD, University of Bologna, Bologna, Italy, and Sigurdur Kristinsson, MD, PhD, University of Iceland, Reykjavík, Iceland, give their highlights from COMy 2022, including thoughts on a cure in multiple myeloma, imaging for patients and iStopMM. This interview took place at the 8th World Congress on Controversies in Multiple Myeloma (COMy) 2022, held in Paris, France.
